Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPCAM-targeted CAR-T for Stomach Cancer
NCT02725125Phase 2Unknown
- Sponsor
- Sinobioway Group Co., Ltd.
- Start
- Nov 2015
- Primary completion
- Nov 2019
- Modality
- Autologous CAR-T
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of IMC001 in gastric cancer (GC), sponsored by Sinobioway Group Co., Ltd. Primary endpoint: Disease control rates at 180 days. Status: unknown.
02
Drugs
IMC001
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02725125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02725125.